Xifaxan 550 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9EY4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,620
Award facts
- Contract value 100% obligated
- $33,620.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,620.49 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Xifaxan 550 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Xifaxan is a rifaxomicin-based antibiotic commonly used to treat traveler's diarrhea and other gastrointestinal infections, reflecting the Defense Logistics Agency's ongoing procurement of pharmaceutical products for military healthcare support.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and federal medical procurement vendor, AmerisourceBergen has demonstrated capability to fulfill federal requirements through competitive awards across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9EY4?
SPE2DR26F9EY4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F9EY4 worth?
The government has obligated $33,620 on SPE2DR26F9EY4.
Is contract SPE2DR26F9EY4 an order under another contract?
Yes. SPE2DR26F9EY4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9EY4 competed?
The extent of competition for SPE2DR26F9EY4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award